Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Centro Studi GISED, Bergamo, Italy.
J Allergy Clin Immunol Pract. 2022 May;10(5):1229-1237.e8. doi: 10.1016/j.jaip.2022.02.018. Epub 2022 Mar 2.
Skin diseases associated with blood or tissue eosinophilia are common. Because these have various clinical manifestations, making the correct diagnosis can be challenging. So far, dermatological patients with concomitant blood eosinophilia have not been characterized.
To investigate patterns of dermatological patients with concomitant blood eosinophilia to obtain information helpful for optimizing disease management.
In this retrospective study, demographic and clinical data and diagnostic test results of all patients presenting with dermatoses associated with blood eosinophilia referred to a university center from 2014 to 2018 were extracted from the electronic patient charts and evaluated using descriptive and semantic map analyses.
A total of 453 patients (51.4% females; mean age, 58.4 ± 21.7 years) were included and grouped according to blood absolute eosinophil counts: severe, greater than or equal to 1.5 G/L (n = 87; 19.2%); moderate, 1.0 to 1.49 G/L (n = 73; 16.1%); and mild eosinophilia, 0.5 to 0.99 G/L (n = 293; 64.7%). Most patients presented with chronic (64.6%), generalized skin lesions (75.9%), and pruritus (88.1%). Statistical analyses revealed 3 distinct patterns: (1) mild eosinophilia associated with localized skin disease, age less than 50 years, history of atopy, and diagnosis of eczema or infectious disease; (2) moderate eosinophilia linked to generalized skin lesions, pruritus, age more than 70 years, and autoimmune bullous disease; and (3) severe eosinophilia associated with diagnosis of hypereosinophilic syndromes, drug hypersensitivity, or malignant disease.
Based on the pattern analysis of patients with dermatoses associated with blood eosinophilia, a diagnostic workup has been developed aiming at setting the correct differential diagnosis in a feasible and effective manner.
与血液或组织嗜酸性粒细胞相关的皮肤疾病很常见。由于这些疾病具有不同的临床表现,因此正确诊断可能具有挑战性。迄今为止,尚未对伴有血液嗜酸性粒细胞增多的皮肤科患者进行特征描述。
研究伴有血液嗜酸性粒细胞增多的皮肤科患者的模式,以获取有助于优化疾病管理的信息。
在这项回顾性研究中,从电子病历中提取了 2014 年至 2018 年期间因血液嗜酸性粒细胞增多相关皮肤病就诊于大学中心的所有患者的人口统计学和临床数据以及诊断检测结果,并使用描述性和语义图分析进行评估。
共纳入 453 例患者(51.4%为女性;平均年龄 58.4 ± 21.7 岁),根据血液绝对嗜酸性粒细胞计数进行分组:重度,≥1.5 G/L(n=87;19.2%);中度,1.0 至 1.49 G/L(n=73;16.1%);轻度嗜酸性粒细胞增多,0.5 至 0.99 G/L(n=293;64.7%)。大多数患者表现为慢性(64.6%)、全身性皮肤病变(75.9%)和瘙痒(88.1%)。统计分析显示存在 3 种不同模式:(1)轻度嗜酸性粒细胞增多与局部皮肤疾病、年龄小于 50 岁、特应病史和湿疹或感染性疾病诊断相关;(2)中度嗜酸性粒细胞增多与全身性皮肤病变、瘙痒、年龄大于 70 岁和自身免疫性大疱性疾病相关;(3)重度嗜酸性粒细胞增多与嗜酸性粒细胞增多综合征、药物过敏或恶性疾病的诊断相关。
基于伴有血液嗜酸性粒细胞增多的皮肤病患者的模式分析,制定了一种诊断性检查方案,旨在以可行和有效的方式确定正确的鉴别诊断。